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AND THE DATA FROM AN EPIDEMIOLOGIC
STUDY ON THE INSULIN RESISTANCE
SYNDROME (D.E.S.I.R.) STUDY GROUP*
OBJECTIVE — Obstructive sleep apnea is common in patients with type 2 diabetes, and its
association with insulin and insulin resistance has been examined in cross-sectional studies. We
evaluate risk factors for incident observed sleep apnea in a general population not selected for
sleep disturbances.
RESEARCH DESIGN AND METHODS — A total of 1,780 men and 1,785 women,
aged33to68years,fromthecohortDatafromanEpidemiologicStudyontheInsulinResistance
Syndrome (D.E.S.I.R.) responded to the question, “Has someone said to you that you stop
breathing during your sleep?” at baseline and 6 years. Anthropometric, clinical, and biological
factors were recorded at both time points.
RESULTS — At baseline, 14% of men and 7% of women reported having observed sleep
apnea (positive response to question); 6-year incidences were 14 and 6%, respectively. Age,
anthropometric parameters, blood pressure, and sleep characteristics were all associated with
prevalent, observed apnea episodes, in both sexes. Baseline waist circumference was the stron-
gest predictor of incident apnea: standardized odds ratio (OR), adjusted for age and sex, 1.34
(95% CI 1.19–1.52). After adjustment for age, sex, and waist circumference, the standardized
ORs for incident observed apnea were identical for fasting insulin and the homeostasis model
assessment of insulin resistance: 1.31 (1.13–1.51) and 1.24 (1.09–1.41) for triglycerides and
1.52 (1.12–2.05) for smoking. Observed apnea at baseline was not associated with changes in
anthropometric or biological parameters over the 6-year follow-up.
CONCLUSIONS — The most important baseline risk factor for incident apnea was adipos-
ity. After accounting for adiposity, other risk factors were high insulin, insulin resistance, high
triglycerides, and smoking, factors amenable to lifestyle intervention.
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bstructive sleep apnea is becoming
more and more recognized as a
health condition because it affects a
considerable proportion of the popula-
tion,inparticularthosewithcardiovascu-
lar diseases, diabetes, and other chronic
diseases (1). Sleep apnea can be classiﬁed
as central if there is no effort or airﬂow
(central apnea has a 1% frequency of all
apnea), obstructive if the respiratory ef-
fort is preserved and increased in the
presence of partial or complete occlusion
on the upper airway, and mixed if there is
a combination of both central and ob-
structiveapnea.Apnearesultsinintermit-
tent hypoxia, recurrent arousals, changes
in intrathoracic pressure, and changes in
sleep architecture (reduction in rapid eye
movement and deep sleep and an excess
in stage 2 sleep). In some cases it is ac-
companied by excessive daytime sleepi-
ness and disturbed sleep. It is diagnosed
byanapnea-hypopneaindex(AHI)of5
episodes per hour during polysomnogra-
phy; apnea is present in 1 in 4 individ-
uals in the general adult population (1).
Sleep apnea is associated with diabetes,
hypertension,andcardiovasculardisease.
In recognition of this association, the In-
ternational Diabetes Federation and the
American Heart Association have both
provided leadership in issuing recom-
mendations for identifying and treating
this condition (2,3). The interrelation be-
tween sleep and the metabolic system is
being increasingly recognized (4,5).
Most of the studies on the epidemiol-
ogy of sleep apnea are either cross-
sectional or case-control studies. The
prospective or longitudinal studies come
from the 4-year follow-up of the Wiscon-
sin Sleep Cohort Study (6) and the 5-year
follow-up of two cohorts, the Cleveland
Family Study (7) and the Sleep Heart
Health Study (8). These three studies all
used polysomnography to quantify sleep
apnea, but the cohorts had an oversam-
pling of individuals likely to have sleep
apnea. In the 1981 Australian Busselton
HealthSurveyofageneralpopulation(9),
the incidence of snoring was studied over
a 13-year follow-up; the risk factors were
sex, obesity, and weight gain.
Themaininterestintheabovestudies
was adiposity, and they showed that age,
sex, and adiposity at baseline and anthro-
pometric changes over follow-up are re-
lated to incident sleep apnea. Among
other factors related to incident sleep-
disorderedbreathingstudiedbyTishleret
al. (7), only cholesterol levels were found
to show a marginal association.
A recent cross-sectional study
showed that both insulin sensitivity and
insulin secretion were related to sleep-
disordered breathing, as evaluated by the
AHI during polysomnography, and the
authors suggested that sleep-disordered
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(10). In this report, we study, after ac-
counting for adiposity, risk factors for in-
cident observed sleep apnea in a
population leaner than that in of most
published reports with mean  SD for
BMI of 25.0  3.8 kg/m
2.
RESEARCH DESIGN AND
METHODS— Participants were re-
cruited into the study Data from an Epi-
demiological Study on the Insulin
Resistance Syndrome (D.E.S.I.R.) be-
tween1994and1996.Theywere30to65
years of age at recruitment and were con-
sultants at Social Security Health Exami-
nation centers in the central western part
of France.
We studied the 1,780 men and 1,785
women who were present at both the
3-year and the 9-year follow-up examina-
tions and who, at both examinations, had
BMI and waist circumference measured
and responded to a question on whether
they had observed sleep apnea, “Has
someonesaidtoyouthatyoustopbreath-
ing during your sleep?” (11). The com-
plete sleep questionnaire is shown in the
online appendix (available at http://care.
diabetesjournals.org/cgi/content/full/dc09-
1901/DC1).Baselinedateforthisanalysis
is 1997–1999, 3 years after inclusion into
the D.E.S.I.R. study.
At baseline and 6 years later, the clin-
ical examinations followed the same pro-
tocol, with examinations by trained
physicians and nurses. Two measures of
blood pressure, using a mercury sphyg-
momanometer were taken with the par-
ticipant in a supine position after a 5-min
rest; mean values were used. Weight and
height were measured in lightly clad par-
ticipants, and BMI was calculated. The
waist circumference, the smallest circum-
ference between the lower ribs and the
iliac crests, was also measured, as well as
the neck circumference.
Smoking habits (current smoker or
not), alcohol consumption (glasses per
day of wine, beer, cider, and spirits, all
transformed to grams per day), and de-
greeofphysicalactivity(peoplewithlittle
activity at home, at work, and in sporting
activities were classiﬁed as physically in-
active) were assessed using a self-
administered questionnaire. All
medications taken by participants were
recorded.
We have deﬁned observed apnea by a
positive response to the question, “Has
someonesaidtoyouthatyoustopbreath-
ing during your sleep?” The sleep ques-
tionnaire (11), as shown in the online
appendix, included the Epworth Sleepi-
ness Scale, which provides a measure of
daytimesleepiness,thatwestudywiththe
reference threshold of 10 or higher,
which was derived in a general popula-
tion (12).
All biochemical measurements were
from one of four health center laborato-
ries located in France at Blois, Chartres,
La Riche, and Orle ´ans. The interlabora-
tory variability for normal and pathologi-
cal values was assessed monthly. Fasting
plasmaglucose,measuredbytheglucose-
oxidase method, was applied to ﬂuoro-
oxalated plasma using a Technicon
RA100 analyzer (Bayer Diagnostics, Pute-
aux,France)oraSpeciﬁcoraDeltadevice
(Konelab, Evry, France). Total choles-
terol, HDL cholesterol, and triglycerides
were assayed with a DAX 24 (Bayer Diag-
nostics) or KONE analyzer (Konelab).
LDL cholesterol was calculated from the
Friedewald equation. A1C was deter-
mined by high-performance liquid chro-
matography (L9100 ion-exchange
analyzer;Hitachi/Merck-VWR,Fontenay-
sous-Bois, France) or an immunoassay
(DCA 2000; Bayer Diagnostics). Insulin
was quantiﬁed by microparticle enzyme
immunoassay with an automated ana-
lyzer (IMX; Abbott, Rungis, France).
Diabetes was deﬁned to include indi-
vidualstreatedfordiabetesandthosewith
a fasting plasma glucose 7.0 mmol/l.
The homeostasis model assessment of in-
sulin resistance (HOMA-IR) index was
used as a surrogate measure of insulin re-
sistance (13).
Statistical analysis
Logarithms of triglycerides and insulin
concentrations and of the HOMA-IR in-
dex have been used in statistical analyses.
All data were analyzed using SAS (version
9.1; SAS Institute, Cary, NC). Data are
presented as means  SD and as percent-
ages. Characteristics of those with and





apnea at 6 years were compared by
ANCOVA, with adjustment for baseline
age, in participants without observed ap-
nea at baseline. Factors measured at base-
line were analyzed according to incident
observed apnea by logistic regression, af-
terverifyingthattherelationswerelinear,
by including squared terms in the regres-
sion analyses; continuous variables were
standardized according to sex, and rela-
tions were adjusted for age and waist cir-
cumference. Sex interactions were tested
for each of these risk factors, and a com-
bined analysis is presented, adjusted for
age, waist, and sex. Results are presented
as standardized odds ratios (ORs). Fur-
ther, to test the homogeneity of the rela-
tion of insulin and the HOMA-IR index
with incident observed apnea, interac-
tionsweretestedacrossBMIclasses:25,
25–30, and 30 kg/m
2.
RESULTS— At baseline, the preva-
lence of reported, observed apnea was
14% in men and 7% in women. Apnea
wasassociatedwithagingandwithhigher
BMI, waist circumference, and neck cir-
cumference (Table 1). After adjustment
for age, all three anthropometric parame-
ters—BMI, waist circumference, and
neck circumference—were higher in
those with observed apnea; the strongest
relation was with waist circumference.
Therewasnointeractionbetweenageand
theseanthropometricparameters.Inboth
men and women, observed sleep apnea
wasassociatedwithothersleepdisorders,
particularly snoring (Table 1). The Ep-
worth Sleepiness Scale was associated
with observed apnea only in men (P 
0.01),withanaveragescoreof6.9inmen
with observed apnea and 6.2 in those
without;therewasnorelationforwomen.
Fasting glucose, A1C, insulin, the
HOMA-IR index, and triglycerides were
all signiﬁcantly and positively associated
with observed apnea in men (all P 
0.006), whereas in women, there were
fewer associations, and those signiﬁcant
were with total and LDL cholesterol and
triglycerideconcentrations(allP0.04).
Bloodpressureswerehigherinthosewith
apnea (all P  0.002). Neither smoking
nor alcohol consumption showed a sig-
niﬁcant relation with observed apnea;
men and women with observed apnea
were more physically inactive than those
without observed apnea (both P 
0.007). Finally, in women 7.1% of those
with observed apnea used hypnotics in
contrast with 2.8% of those without ob-
served apnea (P  0.01). All results were
homogeneous across men and women,
except for total and LDL cholesterol, for
which the interactions with sex were
signiﬁcant.
The incidence of observed apnea was
14% in men and 6% in women, and men
with incident observed apnea were 1 year
older than those without; women were 4
years older (Table 2). In both men and
women, higher baseline BMI and waist
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dentapnea(allP0.006),andinwomen
only baseline neck circumference was
alsorelatedwithincidentobservedapnea,
with a signiﬁcant 0.6 cm larger neck cir-
cumference (P  0.01), in comparison to
only0.3cminmen(P0.1).Increasesin
BMI were associated with incident ob-
served apnea in both men and women
(both P  0.05), and an increase in neck
circumference was also associated in
women (P  0.0001).
Risk factors for incident apnea were
studied separately in men and women
(Table 3), but because there was no sig-
niﬁcantsexinteractionformostoftherisk
factors (data not shown), men and
women were combined for reporting the
relation between cardiometabolic risk
factorsandincidentobservedapnea,after
adjustment for age, waist circumference,
and sex (Table 3). For total cholesterol
and for alcohol intake, there was a
sex interaction, with total cholesterol be-
ing predictive of apnea only in men
(P  0.002); for alcohol, there was only a
marginal relation in either sex. Combining
men and women, insulin (P0.0001), the
HOMA-IR (P  0.0001) index and triglyc-
erides (P0.0009), smoking (P0.006),
andtreatmentbyhypnotics(P0.02)were
related with incident observed apnea; dia-
stolic blood pressure was close to showing
statistical signiﬁcance (P  0.06). In men,
treatment by hypnotics was associated with
a threefold increase in incident observed
apnea.
The relation between insulin and the
HOMA-IR index with incident observed
apnea was homogeneous across BMI
classes for both men and women. Thus,
the observed relation does not seem to be
the result of adiposity (data not shown).
The presence of observed apnea at
baseline was not associated with an in-
crease in adiposity over 6 years. The
changes in waist circumference were 2.0
cm in men with baseline observed apnea
and2.2cminthosewithout(P0.5);for
women the corresponding changes were
1.6 and 2.8 cm (P  0.4). Similarly, the










n (%) 1,524 (86) 256 (14) 1,659 (93) 126 (7)
Age (years) 50  10 53  10 0.0001 50  10 54  9 0.0001
Diabetes 4.7 11.7 0.0001 2.4 2.4 0.9
Anthropometry
BMI (kg/m²) 25.5  3.1 26.6  3.6 0.0001 24.3  4.2 25.8  4.5 0.0003
Waist circumference (cm) 90  99 3  10 0.0001 78  11 82  12 0.0001
Neck circumference (cm) 40  24 1  3 0.0007 34  23 5  3 0.0001
Sleep characteristics
Agitated sleep 16 29 0.0001 23 40 0.0001
Difﬁculty to wake up 25 38 0.0001 42 60 0.0001
Chronic unexplained fatigue 10 18 0.0002 19 31 0.002
Frequent wakening at night 34 45 0.001 46 59 0.006
Snoring 66 89 0.0001 44 71 0.0001
Epworth Sleepiness Scale score 6.2  4.0 6.9  4.1 0.01 5.9  4.2 5.7  4.2 0.6
Epworth Sleepiness Scale score 10 20 27 0.02 20 21 0.8
Biological parameters
Fasting glucose (mmol/l) 5.6  0.9 5.8  1.1 0.006 5.2  0.7 5.2  0.8 0.7
A1C (%) 5.5  0.6 5.6  0.6 0.002 5.4  0.5 5.5  0.6 0.07
Insulin (pmol/l)* 52  32 62  49 0.002 50  34 52  32 0.3
HOMA-IR index* 13.1  9.9 16.9  17.1 0.0006 11.9  10.2 12.6  8.2 0.2
Total cholesterol (mmol/l) 5.8  0.9 5.7  1.0 0.6 5.6  0.9 5.8  1.0 0.04
HDL cholesterol (mmol/l) 1.4  0.4 1.4  0.4 0.4 1.7  0.4 1.6  0.4 0.5
LDL cholesterol (mmol/l) 3.8  0.8 3.7  0.8 0.4 3.5  0.9 3.6  1.0 0.04
Triglycerides (mmol/l)* 1.4  1.2 1.5  1.0 0.006 1.0  0.5 1.1  0.6 0.04
Blood pressure
Systolic (mmHg) 133  15 137  16 0.0002 126  16 133  18 0.0001
Diastolic (mmHg) 80  98 3  10 0.0001 76  97 7  10 0.002
Lifestyle factors
Smoking 21 22 0.7 13 12 0.8
Alcohol (g/day)
01 1 1 2 3 2 3 5
0–20 g/day 26 25 0.8 44 37 0.2
20 g/day 63 64 23 28
Physically inactive 27 36 0.001 26 37 0.007
Drug treatments
Treatment by hypnotics 1.6 2.3 0.4 2.8 7.1 0.01
Data are means  SD or %. *Logarithms taken for analysis.
Hyperinsulinemia and incident sleep apnea
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pmol/l for men with and without baseline
observedapnea(P0.6),andforwomen
the changes were 5.1 and 7.2 pmol/l, re-
spectively(P0.6).Theseresultsdidnot
change after adjustment for age and waist
circumference.
CONCLUSIONS— As in other stud-
ies, this study also shows that adiposity
was related to prevalent and incident ap-
nea, and increases in adiposity over time
were related to incident apnea. Our re-
sults pertain only to observed apnea.
Other factors preceding incident ob-
served apnea, after adjustment for age,
waist circumference, and sex, were insu-
lin, the HOMA-IR index, and triglyceride
concentrations with standardized ORs of
1.31, 1.31, and 1.24, respectively; smok-
ing also increased the risk of incident ob-
served apnea by 50%. Whereas the use of
hypnotics by women at baseline was re-
lated cross-sectionally with observed ap-
nea, with no relation for men, the reverse
was the case for incident observed apnea:
use of baseline hypnotics had an OR of
3.54 in men, despite the fact that fewer
than 2% of the men were treated with
them.
The adverse effect of gaining weight
on sleep-disordered breathing was clear
from the 4-year Wisconsin Sleep Cohort
Study (6): a 10% increase in weight, in
comparison with a stable weight, was as-
sociated with a 32% higher increase in
AHIandasixfoldriskofdevelopingmod-
erate to severe obstructive sleep apnea; a
10% decrease in weight was associated
witha26%decreaseintheAHI.However,






at 6 years P value
Men
n (%) 1,310 (86) 214 (14)
Baseline age (years) 50 51
Baseline BMI (kg/m²) 25.4 26.0 0.006
Baseline waist (cm) 89.3 91.2 0.004
Baseline neck (cm) 39.8 40.1 0.1
Change in BMI (kg/m²) 0.57 0.83 0.02
Change in waist (cm) 2.41 2.75 0.4
Change in neck (cm) 0.42 0.58 0.2
Women
n (%) 1,554 (14) 105 (6)
Baseline age (years) 50 54
Baseline BMI (kg/m²) 24.1 26.2 0.0001
Baseline waist (cm) 77.4 81.8 0.0001
Baseline neck (cm) 34.3 34.9 0.01
Change in BMI (kg/m²) 0.86 1.21 0.05
Change in waist (cm) 3.01 4.16 0.06
Change in neck (cm) 0.40 1.23 0.0001
Data are means unless indicated otherwise.
Table 3—Baseline cardiometabolic risk factors and their standardized ORs (95% CI) for incident observed apnea: the D.E.S.I.R. study
Men P value Women P value
Men and women
combined P value
Number of incident cases (n)/total participants
studied (N)
214/1,524 (14) 105/1,659 (6) 319/3,183 (10)
Age* 1.12 (0.96–1.31) 0.1 1.32 (1.06–1.64) 0.01 1.18 (1.04–1.34) 0.008
Waist circumference† 1.25 (1.07–1.46) 0.004 1.50 (1.24–1.80) 0.0001 1.34 (1.19–1.52) 0.0001
Glucose 1.01 (0.87–1.17) 0.8 1.14 (0.97–1.34) 0.1 1.07 (0.96–1.19) 0.2
A1C 1.04 (0.90–1.20) 0.6 1.04 (0.85–1.27) 0.7 1.05 (0.93–1.18) 0.4
Insulin‡ 1.38 (1.15–1.65) 0.0004 1.19 (0.94–1.50) 0.1 1.31 (1.13–1.51) 0.0002
HOMA-IR index‡ 1.35 (1.13–1.63) 0.0008 1.23 (0.97–1.54) 0.08 1.31 (1.13–1.51) 0.0002
Diabetes§ 0.64 (0.30–1.35) 0.2 1.43 (0.56–3.64) 0.4 0.81 (0.45–1.46) 0.5
Total cholesterol 1.26 (1.08–1.46) 0.002 0.90 (0.72–1.12) 0.3 —
HDL cholesterol 0.93 (0.79–1.10) 0.4 0.86 (0.68–1.09) 0.2 0.90 (0.79–1.03) 0.1
LDL cholesterol 1.18 (1.01–1.37) 0.03 0.91 (0.73–1.12) 0.4 1.10 (0.97–1.24) 0.1
Triglycerides‡ 1.25 (1.07–1.47) 0.004 1.18 (0.94–1.47) 0.1 1.24 (1.09–1.41) 0.0009
Systolic blood pressure 1.06 (0.90–1.24) 0.5 1.02 (0.81–1.28) 0.8 1.05 (0.91–1.19) 0.5
Diastolic blood pressure 1.18 (1.01–1.38) 0.04 1.03 (0.83–1.29) 0.8 1.13 (0.99–1.28) 0.06
Smoking 1.53 (1.08–2.16) 0.02 1.48 (0.79–2.75) 0.2 1.52 (1.12–2.05) 0.006
Alcohol —
0–20 vs. 0 g/day 0.58 (0.32–1.02) 0.06 1.01 (0.64–1.61) 0.9
20 vs. 0 g/day 0.92 (0.57–1.47) 0.07 0.62 (0.36–1.07) 0.1
Physical inactivity 1.17 (1.84–1.63) 0.3 1.03 (1.00–1.05) 0.7 1.11 (0.85–1.44) 0.4
Treatment by hypnotics 3.54 (1.51–8.25) 0.003 1.11 (0.38–3.24) 0.8 2.13 (1.13–4.02) 0.02
Data are ORs (95% CI) unless indicated otherwise. Data are adjusted for age and waist circumference at baseline. The combined analyses have been also adjusted
for sex. *Adjusted for waist circumference only. †Adjusted for age only. ‡Logarithms taken for analysis. §Diabetes deﬁned by medication and/or fasting plasma
glucose 7.0 mmol/l. —, not reported as signiﬁcant interaction between men and women.
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weight-stable population. The Busselton
Health Survey in Australia is one of the
few studies in a general population in
which sleep disorders have been pro-
spectively examined over 15 years. In
the 967 men and women, risk factors
associated with the development of
snoring were sex, baseline obesity, and
weight gain (9); no biochemical mea-
sures were studied.
Other authors have shown cross-
sectional relations between sleep-
disordered breathing and glucose or
diabetes (14,15); however, to our knowl-
edge, there are no other prospective stud-
ies with insulin, glucose, and diabetes as
putative risk factors. In our study, neither
baseline fasting glucose, nor A1C, nor the
presence of diabetes was a risk factor for
incident observed apnea. High insulin
levels and high HOMA-IR index values
werestronglyrelatedtoincidentobserved
apnea, particularly in men. This result
wasindependentoftheeffectsofthemain
risk factors for observed apnea (a large
waist circumference, age, and sex).
We were not able to show the reverse
relations, that the presence of observed
apnea at baseline was associated with
higherinsulinlevelsorgreateradiposity6
years later. Thus, we believe that the high
insulinlevelsseenwithobservedsleepap-
nea, precede this condition, rather than
being caused by it. This analysis partly
answers “the chicken or the egg” question
posed with regard to abdominal fat and
sleepapnea(16).Ithasbeenreportedthat
women with polycystic ovary syndrome
have a 30 times higher risk of having
sleep-disordered breathing (17); insulin
resistance seems to be the primary defect
in these women, which is then followed
by sleep-disordered breathing. There
have been suggestions in the literature
that the improvement in insulin sensitiv-
ity after treatment with continuous posi-
tive airway pressure is evidence that
sleep-disordered breathing may be a
causativeriskfactorforinsulinresistance.
However, there are as many positive as
negative results on this relation in clinical
investigations (15).
A possible mechanism for our obser-
vation that hyperinsulinemia and insulin
resistance precede observed apnea is that
in obesity, the level of pharyngeal dilator
muscle activity may be diminished in the
presence of insulin or insulin resistance,
just as the alteration in arterial muscle
tone that is well recognized in vascular
disease (18). An alternative or additional
mechanism may be the inﬂammation as-
sociated with hyperinsulinemia, insulin
resistance, and abdominal adiposity, pre-
ceding sleep apnea (15).
The cross-sectional associations that
have been shown in the literature among
apnea, cigarette smoking, and alcohol
consumption (14) were not seen in our
study, but we found that smokers had a
50% higher risk of incident observed ap-
neathannonsmokersandthattherewasa
trend for higher alcohol intake in men
only. Physical inactivity has been little
studied in relation to apnea; in our cross-
sectional study, physical inactivity was
more frequent in men and women with
than without observed apnea at baseline,
but it was not associated with incident
observed apnea.
The strength of our study is the large
cohort, drawn from a general population,
with 6 years of follow-up. However, we
must acknowledge the main limitation of
our study: the lack of recorded polysom-
nographic data. Our measure of “ob-
served apnea,” as reported by the
participants in our study, is a crude and
nonobjective measure. A polysomno-
graphic recording was performed in 225
men and women from this cohort: 8 men
and 2 women reported that they had ob-
served apnea; 6 of these men and both
women had an AHI 15 and all had an
AHI 10 (data not published). Further-
more,anargumentfortheuseofobserved
apnea is the observation that in obese in-
dividuals presenting for obesity surgery,
reported observed apnea was the only
symptom related to obstructive sleep ap-
nea (19). These two elements provide
some support for the use of our question
on observed apnea. Reported apnea, ob-
served by another person, is probably the
information that a general practitioner
would have to make a referral, and thus it
is a simple method to screen people re-
quiring further investigation. Another
limitation for the interpretation of our
study is that an individual must have a
sleepingpartnerforapneatobeobserved;
thus, our estimates may be underesti-
mates of the actual frequency, as only in-
dividualswithsevereapneawouldbeable
to report their own. However, the fre-
quencyofapneainthoselivingornotasa
couple was 11 and 9%, i.e., almost iden-
tical,andtheircharacteristicsweresimilar
except that there were more women who
reported that they were living alone. We
do not have a direct measure of insulin
resistance, and we have used both insulin
and the HOMA-IR index as surrogate
measures. However, hyperinsulinemia
andinsulinresistancedonotalwaysoccur
together (20,21), and the HOMA-IR in-
dex and insulin have similar correlations
with clamp-measured insulin sensitivity
in a nondiabetic population (Spearman
correlation coefﬁcients; 0.505 and
0.525,respectively,fromtheRelationship
between Insulin Sensitivity and Cardio-
vascular Disease [RISC] study) (20,21).
Adiposity was strongly related to in-
cidentapnea,butafteraccountingforthis
relation, the risk of observed apnea also
increased with increasing insulin levels
and with an increasing HOMA-IR index.
Thisistheﬁrstreportthathasbeenableto
show that hyperinsulinemia and an insu-
lin resistance index are predictive of later
apnea, albeit observed apnea, after ac-
counting for adiposity and changes in ad-
iposity. Limiting weight gain is the
simplest but probably the hardest-to-
achieve preventive strategy for sleep ap-
nea. Increasing physical activity and
limiting sedentary behavior could play a
role in increasing insulin sensitivity (22)
and decreasing the risk for apnea.
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